Senior insider sale
CEO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$4.57M
118.76K shares
What this filing means
PIMSTONE SIMON N. plans to sell 118.76K shares of XENON PHARMACEUTICALS INC. valued at approximately $4.57M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/31/2023ACC: 0000950170-23-025496
DirectorOfficer· CEO
Since Sep 2019
118.76K
Shares to sell
$4.57M
Approx. market value
62.53K
Acquired (3 months)
2
Planned
2 completed
Securities Acquired — Last 3 Months2
Exercise of Options
Net Exercise
5/31/2023
50.53KExercise of Options
Net Exercise
3/7/2023
12KTotal acquired62.53K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/31/2023 | Exercise of Options Net Exercise | 50.53K | — |
3/7/2023 | Exercise of Options Net Exercise | 12K | — |
| Total | 62.53K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
37.01K
Market value
$1.45M
5/30/2023
—Completed
Units to sell
19.23K
Market value
$711.2K
3/7/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
50.53K
Market value
$1.95M
5/31/2023
NASDAQPlanned
Units to sell
12K
Market value
$462.4K
5/31/2023
Total
Units
118.76K
Value
$4.57M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/30/2023 | 37.01K | $1.45M | — | Completed |
3/7/2023 | 19.23K | $711.2K | — | Completed |
| Planned — Approximate Date | ||||
5/31/2023 | 50.53K | $1.95M | NASDAQ | Planned |
5/31/2023 | 12K | $462.4K | NASDAQ | Planned |
| Total | 118.76K | $4.57M | ||